网站主页 > 化工产品目录 > 生物化工 > 抑制剂 > 血管生成(Angiogenesis) > Bcr-Abl 抑制剂 > 3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺

3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺

3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺 更多供应商
公司名称: 上海波以尔化工有限公司  
联系电话:
产品介绍: 中文名称:3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺
英文名称:GNF-2
CAS:778270-11-4
公司名称: 上海佰世凯化学科技有限公司  
联系电话: 021-20908456
产品介绍: 英文名称:GNF-2
CAS:778270-11-4
备注:C14587
公司名称: 济南精合医药科技有限公司  
联系电话: +86 (531) 88811783
产品介绍: 英文名称:GNF-2
CAS:778270-11-4
纯度:99% 包装信息:5Mg, 10Mg, 20Mg, 50Mg
公司名称: 上海岚克医药科技发展有限公司  
联系电话: 0086-21-58956006
产品介绍: 英文名称:GNF-2
CAS:778270-11-4
纯度:98% 包装信息:1KG;10KG 备注:100g/1kg大量均可
公司名称: BOC Sciences  
联系电话: 16314854226
产品介绍: 英文名称:GNF-2
CAS:778270-11-4
最新发布供应信息
3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺_广州贝尔卡生物科技有限公司
2021/8/4 8:45:43
Bcr-Abl抑制剂(GNF-2)_上海泽叶生物科技有限公司
2021/8/3 13:22:00
3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺
生物活性靶点体外研究体内研究
中文名称:3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺
中文同义词:3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺;BCR-ABL抑制剂(GNF-2)
英文名称:GNF-2
英文同义词:3-[6-[[4-(Trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]benzamide GNF-2;GNF-2 3-[6-[[4-(Trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]benzamide;GNF 2, >=98%;3-(6-(4-(TRIFLUOROMETHOXY)PHENYLAMINO)PYRIMIDIN-4-YL)BENZAMIDE;Benzamide, 3-[6-[[4-(trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]-;GNF-2;Bcr-abl Inhibitor;3-[6-[[4-(Trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]benzamide
CAS号:778270-11-4
分子式:C18H13F3N4O2
分子量:374.32
EINECS号:200-256-5
相关类别:小分子抑制剂;小分子抑制剂,天然产物;血管生成;细胞生物学试剂;Inhibitors
Mol文件:778270-11-4.mol
3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺
3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺 性质
储存条件 2-8°C
溶解度 H2O: <2mg/mL
形态White solid
颜色off-white
3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺 用途与合成方法
生物活性GNF-2 是一种具有高度选择性、变构的、非 ATP 竞争性 Bcr-Abl 抑制剂。 GNF-2 抑制 Ba/F3.p210 增殖, IC50 为 138 nM。
靶点

Bcr-Abl

体外研究

GNF-2 selectively inhibits Bcr-abl-dependent cell proliferation. GNF-2 (0.005-10 μM; 48 hours) specifically inhibits the proliferation of the Bcr-abl-expressing cells with an IC 50 of 138 nM and not show any cytotoxic effects on the nontransformed cells at concentrations of up to 10 μM. GNF-2 (0.005-10 μM; 48 hours) causes a dose-dependent growth inhibition of the Bcr-abl-positive cell lines with IC 50 values of 273 nM (K562) and 268 nM (SUP-B15). GNF-2 (0.005-10 μM; 48 hours) inhibits E255V and Y253H mutant Bcr-abl cell growth (IC 50 values of 268 and 194 nM, respectively).
GNF-2 (1-10 μM; 48 hours) induces apoptosis of Bcr-abl-transformed cells.
GNF-2 (0.1-10 μM; 90 minutes) inhibits the cellular tyrosine phosphorylation of Bcr-abl in a dose-dependent manner with an IC 50 of 267 nM.

Cell Proliferation Assay

Cell Line: Ba/F3.p210, Ba/F3.p210 E255V and Ba/F3.p185 Y253H cells
Concentration: 0.005, 0.01, 0.1, 1, 10 μM
Incubation Time: 48 hours
Result: Inhibited Bcr-abl-transformed cells proliferation.

Apoptosis Analysis

Cell Line: Ba/F3.p210 and Ba/F3.p210 E255V cells
Concentration: 1, 10 μM
Incubation Time: 48 hours
Result: Increased number of Ba/F3.p210 cells undergoing apoptosis at 1 μM for 48 h.
Ba/F3.p210 E255V underwent apoptotic death after 48 h incubation in the presence of 1 μM or higher concentration.

Western Blot Analysis

Cell Line: Ba/F3.p210 and Ba/F3.p210 E255V cells
Concentration: 0.1, 1, 10 μM
Incubation Time: 90 minutes
Result: Decreased the autophosphorylation levels at a concentration of 1 μM and were barely detectable at 10 μM, whereas the level of total Bcr-abl remained unchanged.
Induced a significant decrease in the levels of p-Stat5 (at Y694) at 1 μM in Ba/F3.p210 and Ba/F3.p210 E255V cells.
体内研究

GNF-2 (10 mg/kg; i.p. for 8 days) protects LPS (5 mg/kg) induced bone erosion in mice. GNF-2 protects the LPS induced bone loss and abrogates the LPS-induced decreases of bone volume/tissue volume (BV/TV) of LPS-treated mice.
GNF-2 prevents the LPS-induced increases of N.Oc/B.Pm, the percentage of Oc.S/BS, and the percentage of ES/BS.

Animal Model: Eight-week-old C57/BL6 mice were administered i.p. injections of LPS (5 mg/kg)
Dosage: 10 mg/kg
Administration: I.p. injections for 8 days; 1 day before and every day after the LPS injection
Result: Prevented inflammatory bone destruction in vivo.
安全信息
危险品标志 Xi
危险类别码 36/37/38
安全说明 26
WGK Germany 3
"3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺" 相关产品信息()
[双(三氟乙酰氧基)碘]苯 三氯氧磷 4-三氟甲氧基苯基异氰酸酯 阿西替尼 GNF-5 GNF-7 PI-103 司美替尼 曲美替尼 喜树碱 4-氨基-N-[(1S)-1-(4-氯苯基)-3-羟基丙基]-1-(7H-吡咯并[2,3-D]嘧啶-4-基)-4-哌啶甲酰胺